These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 384595)

  • 1. Arachidonic acid-induced platelet aggregation independent of ADP-release in a patient with a bleeding disorder due to platelet storage pool disease.
    Minkes MS; Joist JH; Needleman P
    Thromb Res; 1979; 15(1-2):169-79. PubMed ID: 384595
    [No Abstract]   [Full Text] [Related]  

  • 2. Defective platelet aggregation to the calcium ionophore A23187 in a patient with a lifelong bleeding disorder.
    Machin SJ; Keenan JP; McVerry BA
    J Clin Pathol; 1983 Oct; 36(10):1140-4. PubMed ID: 6413552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alteration of release and role of adenosine diphosphate and thromboxane A2 during collagen-induced aggregation of platelets from cattle with Chediak-Higashi syndrome.
    Honda N; Ohnishi K; Fujishiro T; Ikeda M; Ito K
    Am J Vet Res; 2007 Dec; 68(12):1399-406. PubMed ID: 18052747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testosterone potentiation of ionophore and ADP induced platelet aggregation: relationship to arachidonic acid metabolism.
    Pilo R; Aharony D; Raz A
    Thromb Haemost; 1981 Aug; 46(2):538-42. PubMed ID: 6795741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet-activating factor (PAF-acether) secretion from platelets: effect of aggregating agents.
    Chignard M; Le Couedic JP; Vargaftig BB; Benveniste J
    Br J Haematol; 1980 Nov; 46(3):455-64. PubMed ID: 6778498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of rabbit platelet aggregation by 1,4-naphthoquinones.
    Ko FN; Sheu SJ; Liu YM; Huang TF; Teng CM
    Thromb Res; 1990 Feb; 57(3):453-63. PubMed ID: 2156351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of heparin on platelet aggregation and release and thromboxane A2 production.
    Mohammad SF; Anderson WH; Smith JB; Chuang HY; Mason RG
    Am J Pathol; 1981 Aug; 104(2):132-41. PubMed ID: 7258300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of etamsylate on platelet functions and arachidonic acid metabolism.
    Okuma M; Takayama H; Sugiyama T; Sensaki S; Uchino H
    Thromb Haemost; 1982 Dec; 48(3):330-3. PubMed ID: 6819650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A dominant role of thromboxane formation in secondary aggregation of platelets.
    Meyers KM; Seachord CL; Holmsen H; Smith JB; Prieur DJ
    Nature; 1979 Nov; 282(5736):331-3. PubMed ID: 503210
    [No Abstract]   [Full Text] [Related]  

  • 10. Sodium arachidonate can induce platelet shape change and aggregation which are independent of the release reaction.
    Kinlough-Rathbone RL; Reimers HJ; Mustard JF; Packham MA
    Science; 1976 Jun; 192(4243):1011-2. PubMed ID: 1273582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel inhibitory actions on platelet thromboxane and inositolphosphate formation by xanthones and their glycosides.
    Teng CM; Lin CN; Ko FN; Cheng KL; Huang TF
    Biochem Pharmacol; 1989 Nov; 38(21):3791-5. PubMed ID: 2512926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological characterization of cinnamophilin, a novel dual inhibitor of thromboxane synthase and thromboxane A2 receptor.
    Yu SM; Wu TS; Teng CM
    Br J Pharmacol; 1994 Mar; 111(3):906-12. PubMed ID: 8019768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of granulocyte elastase-like proteinase (ELP) on platelet functions.
    Taki M; Miura T; Inagaki M; Tomita Y; Saito N; Okada Y; Tsuda Y; Meguro T; Yamada K
    Thromb Res; 1986 Mar; 41(6):837-46. PubMed ID: 3010492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Requirement of ADP for arachidonic acid-induced platelet aggregation: studies with selective thromboxane-synthase inhibitors.
    Cerletti C; Minoldo S; Bucchi F; Del Maschio A; de Gaetano G
    Biochem Pharmacol; 1986 Apr; 35(7):1201-3. PubMed ID: 3083818
    [No Abstract]   [Full Text] [Related]  

  • 15. Deficiency of (33P)2MeS-ADP binding sites on platelets with secretion defect, normal granule stores and normal thromboxane A2 production. Evidence that ADP potentiates platelet secretion independently of the formation of large platelet aggregates and thromboxane A2 production.
    Cattaneo M; Lombardi R; Zighetti ML; Gachet C; Ohlmann P; Cazenave JP; Mannucci PM
    Thromb Haemost; 1997 May; 77(5):986-90. PubMed ID: 9184415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Membrane protein mediation of thromboxane A2-induced platelet aggregation.
    Kao KJ; Hagen PO; Pizzo SV
    Biochem Biophys Res Commun; 1980 Nov; 97(1):87-93. PubMed ID: 6779820
    [No Abstract]   [Full Text] [Related]  

  • 17. [Studies on platelets in a patient with a novel hereditary platelet function disorder--impaired aggregation in response to A 23187 with normal response to arachidonic acid].
    Sugiyama T; Okuma M; Ushikubi F; Kanaji K; Sensaki S; Uchino H; Hattori A; Ihzumi T
    Rinsho Ketsueki; 1986 Oct; 27(10):1834-42. PubMed ID: 3102812
    [No Abstract]   [Full Text] [Related]  

  • 18. Platelet dysfunction in uremia. Multifaceted defect partially corrected by dialysis.
    Di Minno G; Martinez J; McKean ML; De La Rosa J; Burke JF; Murphy S
    Am J Med; 1985 Nov; 79(5):552-9. PubMed ID: 3933340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormalities of aggregation, thromboxane A2 synthesis, and 14C serotonin release in platelets of patients with idiopathic scoliosis.
    Floman Y; Liebergall M; Robin GC; Eldor A
    Spine (Phila Pa 1976); 1983 Apr; 8(3):236-41. PubMed ID: 6623192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the formation and effects of thromboxane A2 in human platelets.
    Svensson J; Hamberg M; Samuelsson B
    Acta Physiol Scand; 1976 Nov; 98(3):285-94. PubMed ID: 998278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.